首页> Contrast media & molecular imaging> Prognostic Value of <sup>18</sup>F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel.

Prognostic Value of <sup>18</sup>F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel.

导出 OA

翻译打印收藏纠错

第一作者： E,Quaquarini

第一单位： Medical Oncology Unit, ICS Maugeri SpA SB-IRCCS, Pavia 27100, Italy.;University of Pavia, Ph.D. in Experimental Medicine, Pavia 27100, Italy.

作者： E,Quaquarini ^[1] ; D,D'Ambrosio ^[2] ; F,Sottotetti ^[3] ; F,Gallivanone ^[4] ; M,Hodolic ^[5] ; P,Baiardi ^[6] ; R,Palumbo ^[3] ; C,Vellani ^[7] ; C,Canevari ^[8] ; A,Bernardo ^[3] ; I,Castiglioni ^[4] ; C,Porta ^[9] ; G,Trifirò ^[7]

作者单位： Medical Oncology Unit, ICS Maugeri SpA SB-IRCCS, Pavia 27100, Italy.;University of Pavia, Ph.D. in Experimental Medicine, Pavia 27100, Italy. ^[1] Medical Physics Unit, ICS Maugeri SpA SB-IRCCS, Pavia 27100, Italy. ^[2] Medical Oncology Unit, ICS Maugeri SpA SB-IRCCS, Pavia 27100, Italy. ^[3] Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Milan 20090, Italy. ^[4] Nuclear Medicine Research Department, Iason, Graz, Austria.;Nuclear Medicine Department, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic. ^[5] Scientific Direction, ICS Maugeri SpA SB-IRCCS, Pavia 27100, Italy. ^[6] Nuclear Medicine Unit, ICS Maugeri SpA SB-IRCCS, Pavia 27100, Italy. ^[7] Nuclear Medicine Unit, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy. ^[8] Translational Oncology Unit, ICS Maugeri SpA SB-IRCCS, Pavia 27100, Italy.;University of Pavia, Department of Internal Medicine, Pavia 27100, Italy. ^[9]